Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

Kent State University Will Offer High Level Biosafety Training

Published 11/3/2009

The National Biosafety and Biocontainment Training Program will offer biosafety training in Kent State University’s Cunningham Hall in Ohio. Providing education for professionals working in BSL-3 and BSL-4 laboratories, the facility is the second location in the country to provide training in high level biocontainment operations.

Read More

Georgia Southern University Builds Biocontainment Lab

Published 10/29/2009

Georgia Southern University is constructing the Public Health Core Research Lab in Statesboro. Part of the Jiann-Ping Hsu College of Public Health, the facility is comprised of two BSL-3 research labs, two teaching labs, and two chemistry labs. Completion is expected in 2010.

Read More

Canadian Science Centre for Human and Animal Health Initiates Expansion

Published 10/29/2009

The Canadian Science Centre for Human and Animal Health is initiating a $16.5 million expansion and renovation of its Winnipeg research facility. Designed by Smith Carter and built by PCL Constructors, the project includes a 1,600-sm, three-story laboratory addition and infrastructure upgrades to the National Microbiology Laboratory and the National Centre for Foreign Animal Disease. Completion is expected by March of 2011.

Read More

Haffkine Institute Builds BSL-3 Lab

Published 10/22/2009

The Haffkine Institute is installing a pre-fabricated BSL-3 laboratory in Parel, Mumbai. Created by M+W Zander, the facility will support infectious disease testing for HINI, avian influenza, and other zoonotic agents. The laboratory will include biosafety cabinets, advanced air filtration, and a dedicated effluent decontamination system.

Read More

SAFC Pharma Opens BSL-2 Facility

Published 10/13/2009

SAFC Pharma completed the expansion of its $12 million contract manufacturing facility in October of 2009. Located in Carlsbad, Calif., the BSL-2 project features two fully segregated viral product manufacturing suites. Utilizing disposable bioreactor technologies, the expansion will enable SAFC Pharma to produce biologics, viral vaccines, and gene therapies in commercial-scale quantities. The facility includes dedicated cell expansion, bioreactor production, purification, and cleanroom suites. The project added 8,000-sf to the existing 44,000-sf building.

Read More